search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The Active and Healthy Aging Study (Dutch: Actief en Gezond Oud Studie).


- candidate number10271
- NTR NumberNTR3045
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR24-aug-2011
- Secondary IDsP10.220 METC LUMC
- Public TitleThe Active and Healthy Aging Study (Dutch: Actief en Gezond Oud Studie).
- Scientific TitleThe Active and Healthy Aging Study (Dutch: Actief en Gezond Oud Studie).
- ACRONYMAGO Study
- hypothesisInternet-based coaching combined with accelorometry of inactive individuals aged 60-70 years is effective in increasing physical activity, and this increase in physical activity associates with enhanced 24-hour glucose regulation.
- Healt Condition(s) or Problem(s) studiedAging, Glucose metabolism, Physical activity, Lifestyle intervention, Self-monitoring
- Inclusion criteria1. Age 60 to 70 years;
2. Sedentary lifestyle;
3. Motivated to increase physical activity;
4. Familiar with use of and access to personal computer.
- Exclusion criteria1. Physical condition that inhibits increase of physical activity;
2. Diabetes mellitus type I or II;
3. Use of glucose lowering medication.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2011
- planned closingdate1-nov-2012
- Target number of participants232
- InterventionsThe study is an open, randomized controlled intervention trial. Participants will be randomized to DirectLife intervention or control group. The control group will be offered use of DirectLife after the end of the study, i.e. the second "assessment period", such that all participants will receive an equal amount of study visits, and can both benefit from the DirectLife program.

Philips DirectLife has developed a lifestyle activity intervention program, DirectLife, to increase people's daily life physical activity. Based on health behavior change models (Prochaska et al., 1994; Vries and Mudde, 1998), DirectLife takes into account the current individual activity level, and subsequently provides a personal goal. Very briefly, DirectLife consists of three elements, namely:
1. An activity monitor;
2. A personal website;
3. A personal e-coach, who provides regular updates by e-mail of the physical activity status and gives advice to increase physical activities.
By means of these elements, DirectLife increases awareness about one's own physical activity behavior, gives feedback, and provides support to make sustainable changes in physical activity behavior.
DirectLife has a scientific base. The activity monitor of DirectLife is based on the Tracmor, i.e. a tri-axial accelerometer, which has been reviewed as the most accurate device for the estimation of total daily life energy expenditure (Bonomi et al., 2010; Plasqui et al., 2005; Plasqui and Westerterp, 2007). Moreover, DirectLife combines high-tech with human elements to help people to change to a more active lifestyle (Goris and Holmes, 2008). Participants of the DirectLife program continuously wear an accelerometer throughout the day to measure daily activity. These data are uploaded through the internet. After an initial "assessment period" in which the current level of daily activity is measured, a target is set to increase the level of daily activity during a twelve week web based interactive coaching program. Participants are given a target for daily activity which increases weekly, and data from the accelerometer are used for regularly feedback.
- Primary outcomeLevel of daily activity, as measured using independent tri-axial accelerometers. These accelerometers have been validated against energy expenditure measured using VO2-max. We will use this independent measure of activity, because: A. The DirectLife activity monitor is part of the intervention therefore not independent not suitable as measure of end point;
B. The Genea accelerometer yields more detailed data on physical activity.
- Secondary outcome1. Other metabolic and anthropometric parameters: weight, waist hip ratio, body fat percentage (BIA) and blood pressure will be measured at baseline and at the final visit, and blood sampling for total cholesterol, HDL-cholesterol, triglycerides, fasting glucose, fasting insulin and HbA1c;
2. Well being and perceived health will be assessed by RAND-36 questionnaire prior to the trial and after the trial;
3. Sleep quality will be assessed by the Pittsburg Sleep Quality Index (PSQI).
- TimepointsT=0: Baseline visit for assessment of physical activity, glucose monitoring, blood sampling and anthropometrics;
T=1 wk to T=13 wk: Intervention or control period;
T = 13 wks: End visit for assessment of PA, glucose monitoring, blood sampling and anthropometrics.
- Trial web sitewww.agostudie.nl
- statusstopped: trial finished
- CONTACT FOR PUBLIC QUERIES Simon Mooijaart
- CONTACT for SCIENTIFIC QUERIES Simon Mooijaart
- Sponsor/Initiator Leiden University Medical Center (LUMC)
- Funding
(Source(s) of Monetary or Material Support)
Netherlands Consortium for Healthy Ageing, Philips Health Care
- PublicationsN/A
- Brief summaryWith an increasingly ageing population, there is a need for lifestyle interventions that can be implemented at a population level to improve health in old age and increase healthy lifespan in the general population. Healthy longevity has been associated with enhanced glucose tolerance and insulin sensitivity, characteristics that can be modified by increasing physical activity. The Philips Directlife program is a web-based lifestyle intervention directed at increasing daily physical activity consisting of 1) an activity monitor, 2) a personal website, and 3) a personal e-coach. Glucose metabolism can be measured with minimal invasive measures and sensitively using a 24-hour glucose sensor (continuous glucose measurement, CGM) placed subcutaneously in the abdomen. This study will test the following hypotheses:
Primary: The DirectLife program is effective in increasing the level of physical activity in an ageing population.
Secondary:
1. The level of physical activity associates with parameters of 24-hour glucose rhythms in an ageing population;
2.An increase in physical activity associates with beneficial changes in 24-hour glucose rhythms as measured with CGM, and with changes in metabolic parameters, anthropometry, well-being and sleep quality.
We will perform a randomized controlled trial in 316 participants aged 60-70 year with sedentary lifestyle. We will apply the Philips Directlife program as intervention vs. no intervention in the control group. The primary outcome is change in daily physical activity, as measured by independent tri-axial accelerometers. Secondary outcome parameters include parameters measured during 24-hour glucose rhythms, such as mean glucose, standard deviation of the mean, postprandial glucose rhythms etc., and metabolic parameters, well-being and sleep quality. The overview of the study is shown in figure 1. Shortly, participants are recruited from the general population and screened for physical activity level using questionnaire. The study outline comprises two visits to the study center. The primary visit is at t=0 weeks during which baseline anthropometric measurements and well-being are assessed and the CGM sensor applied which is worn for 4 days. The second visit is at t=14 weeks, after which outcome parameters are assessed and CGM applied for the second time to be worn for four days. After t=14 weeks, the control group will get access to the Philips DirectLife program after the study has ended.
- Main changes (audit trail)
- RECORD24-aug-2011 - 19-nov-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl